Hematology Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test (Blood Count, Platelet Function, Hemoglobin, Hematocrit), By End Use, By Region, And Segment Forecasts, 2025 - 2030

Hematology Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test (Blood Count, Platelet Function, Hemoglobin, Hematocrit), By End Use, By Region, And Segment Forecasts, 2025 - 2030

Hematology Diagnostics Market Growth & Trends

The global hematology diagnostics market size is expected to reach USD 5.93 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 6.6% from 2025 to 2030. Increasing prevalence of blood disorders coupled with adoption of automated testing processes are projected to propel the market growth.

Automation of hematology diagnostics process have led to reduced turnaround time thereby accelerating the overall treatment regimen. Furthermore, automation has also led to reduced administrative errors and overall costs of diagnostic tests. Thus, it is expected to boost growth of the hematology testing market in the forthcoming years.

Dominance of hematology analyzers can be attributed to the presence of fully-automated analyzers which are objective, have high-throughput, and are cost-effective. Furthermore, these hematology analyzers can also detect atypical results and can improve measurable parameters such as red cell distribution width, platelet distribution, Reticulocyte (RET) counts, and nucleated red cells counts.

The advent of Point-Of-Care (PoC) hematology testing devices has led to improved diagnostic and patient outcomes. These devices are user-friendly and are available for use outside the hospital settings. This is anticipated to increase the acceptability and accessibility of hematology testing which, in turn, is anticipated to propel market growth.

Product recall and intense market competition leading to price wars are anticipated to hinder market growth. In 2018, Becton Dickinson (BD) and Company recalled Vacutainer EDTA Blood Collection Tubes owing to chemical interference with certain tests. This recall was classified as Class I recall, the most serious type of recall, by the Food and Drug Administration (FDA), thereby indicating that the use of these devices may cause serious injuries or death. Such product recalls can negatively affect the market growth.

Hematology Diagnostics Market Report Highlights

• The consumables segment dominated the market with a share of 66.0% in 2023 and is also expected to witness the fastest growth with a CAGR of 6.9% in the forecast period.
• The blood count segment captured the largest revenue share at 45.0 % in 2024. Organizations such as the American Cancer Society are rising awareness about diseases and chronic conditions such as Neutropenia, which are caused low WBC counts, propelling the population towards having frequent WBCs test.
• The hospital segment held the largest revenue share of 41.0% in 2024. This is attributable to growing hematology diagnostics demand in forensic labs and hospital medical labs for disease diagnosis, blood cell counts, detecting illegal drug use, monitoring therapeutic drug levels, protein analysis, blood typing, thyroid function assessment, and detecting the presence of antibodies.
• North America hematology diagnostics market dominated the market and accounted for a 45.0 % share in 2024.

Please note The report will be delivered in 2-3 business days upon order notification.